Brian Nowosielski

The AI-led initiative was designed to conduct audits and ensure appropriate distribution of health care funds for federal programs.

In an evolving health care landscape bringing all providers into a primary care team, diabetes is no different and the pharmacist community can offer so much for patients.

Recent research data assessed the potential use of GLP-1s for reducing the progression of total knee arthroplasty.

Episode 10 addresses recent changes to the AACE diabetes guidelines and what pharmacists need to do to stay informed.

In part 2 of our interview with Sandra Leal, PharmD, MPH, she explored the ADA Standards of Care and how pharmacists are positioned to assist in interoperable diabetes management.

Exploring both the PCV20 and PCV21 pneumococcal vaccines, researchers compare the differences in immune effects between patients at 50 and 65 years old.

With insights from executives working around the clock to advance the pharmacy profession, our experts predicted what the landscape will look like following the Consolidated Appropriations Act of 2026.

Pharmacist and diabetes expert Sandra Leal, PharmD, MPH, joins to discuss the importance of engaging pharmacists within primary care diabetes teams.

In a meta-analysis conducted between 2013 and 2023, researchers explore the overall impact of interventions geared toward boosting pneumococcal vaccination rates.

Featuring pharmacist and entrepreneur Sam Maddula, PharmD, this episode explores some key legislative and regulatory insights regarding owning and operating a pharmacy business.

Represented by Frier Levitt, multiple hospital systems filed lawsuits on May 21, 2026, targeting a variety of entities existing under CVS Health.

In a health care landscape of silos and fragmentation, especially in the menopause space, pharmacists have increasingly provided their efforts to better care coordination for their communities.

From supporting MTM services to reaching unhoused populations, the 340B program is a powerhouse for patient care, access, and affordability.

This month’s event will explore policy, people, and profitability, and how pharmacy businesses can transform these factors toward actionable solutions.

In this episode, host Taylor Watterson, PharmD, PhD, provides a deeper look into workplace fatigue and the metrics used to calculate and facilitate it.

In part 2, Miller further breaks down the fragmentation of menopause care within today’s health care system and how pharmacists are uniquely positioned to fill in long-standing care gaps.

Across rural US community pharmacies, researchers explore the common barriers and facilitators to pneumococcal vaccine uptake.

Two separate bills were marked up in House committees last week and were officially advanced to potentially move additional PBM reform into law.

Lisa Miller, PharmD, MSCP, discusses fragmentation in US menopause care and the role pharmacists can play in improving collaboration.

Exploring pneumococcal vaccination rates among eligible adult patients, researchers conducted a quality improvement initiative at a clinic in Illinois.

Researchers hope to inform national strategies on pharmacists’ potential place in asthma management.

The proposed bill would force pharmacy benefit managers to act on the interests of pharmacies rather than their own companies.

From PBM reform and AI to burnout and closures, Tom DePietro, PharmD, addresses the current state of independent pharmacy.

Results of Eli Lilly’s investigational triple agonist were reported in the TRIUMPH-1 Phase 3 clinical trial.

Although currently contained outside of the US, the Bundibugyo strain of the virus reached an American worker in the Democratic Republic of Congo.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Sarah Chew, MPH, to discuss the pharmacist’s role in advancing women’s health research.

In part 2, Tom DePietro, PharmD, explores emerging topics of interest within community pharmacy, including AI, PBMs, and the industry’s evolving nature.

With Commissioner Makary resigning just days prior, this marks the second and third major change in the federal agency’s leadership this month.

Jeffery Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases, provided his expert perspectives on the ongoing hantavirus outbreak.

Between clinical initiatives, educational strategies, and regulatory frameworks, researchers explore PGx services integration.